Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration.
Although pigment epithelium-derived factor (PEDF) is a neurotrophic factor that may aid the development, differentiation, and survival of adjacent neural retinae, the wider distribution of PEDF mRNA in the central nervous system suggested to us that this factor could have pleiotropic neurotrophic and neuroprotective effects on nonretinal neurons. We examined the distribution of PEDF mRNA and its transcript in the spinal cord. By immunohistochemistry and western blot analysis using an antihuman PEDF antiserum of known specificity, we found that PEDF protein is present in spinal cord, cerebrospinal fluid, and skeletal muscle and that its mRNA appears concentrated in motor neurons of the human spinal cord. These observations indicate that PEDF could have potential autocrine and paracrine effects on motor neurons, as well as being target-derived. We analyzed the pharmacologic utility of PEDF in a postnatal organotypic culture model of motor neuron degeneration and proved it is highly neuroprotective. The effect was biologically important, significantly sparing the spinal cord's gross organotypic morphological appearance and preserving motor neuron choline acetyltransferase (ChAT). PEDF alone did not increase ChAT, indicating that the observed effect is neuroprotective, not merely an upregulation of motor neuron ChAT. Further, PEDF preserved motor neuron number, proving a survival effect. We hypothesize that PEDF may play important roles in the survival and maintenance of spinal motor neurons in their neuroprotection against acquired insults in postnatal life. It should be developed further as a therapeutic strategy for motor neuron diseases such as amyotrophic lateral sclerosis (ALS).
Bilak
M M
MM
Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.
Corse
A M
AM
Bilak
S R
SR
Lehar
M
M
Tombran-Tink
J
J
Kuncl
R W
RW
D000818:Animals; D002417:Cattle; D002470:Cell Survival / Q000502:physiology; D002555:Cerebrospinal Fluid / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002908:Chronic Disease; D004805:Ependyma / Q000378:metabolism; D005136:Eye Proteins; D005260:Female; D018698:Glutamic Acid / Q000506:poisoning; D000882:Haplorhini; D006801:Humans; D009046:Motor Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018482:Muscle, Skeletal / Q000378:metabolism; D009410:Nerve Degeneration / Q000139:chemically induced* / Q000473:pathology*; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009924:Organ Culture Techniques; D011506:Proteins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D015843:Serpins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D013116:Spinal Cord / Q000166:cytology / Q000378:metabolism; D000099174:Pigment Epithelium-Derived Factor
D002795:Choline O-Acetyltransferase; D005136:Eye Proteins; D018698:Glutamic Acid; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D011506:Proteins; D012333:RNA, Messenger; D015843:Serpins; D000099174:Pigment Epithelium-Derived Factor